Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$191.89 - $259.92 $1.29 Million - $1.74 Million
-6,700 Reduced 98.53%
100 $20,000
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $1.34 Million - $1.7 Million
6,800 New
6,800 $1.48 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $326,608 - $483,839
1,600 New
1,600 $342,000
Q1 2022

May 16, 2022

SELL
$255.51 - $362.11 $25,551 - $36,211
-100 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $35,138 - $44,868
100 New
100 $38,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.